Search Results - "Mebarki, S"

Refine Results
  1. 1

    First principles study of ternary chalcogenide Sn2Sb2S5 compound for opto-electronic applications by Bennouar, K., Hadjri Mebarki, S., Ouahrani, T.

    Published in Optik (Stuttgart) (01-09-2020)
    “…•Structural, chemical bonding, and electronic band structure data are reported at zero pressure for crystalline Sn2Sb2S5 from first-principles…”
    Get full text
    Journal Article
  2. 2

    Numerical study of hemodynamics after stent implantation during the cardiac cycle by Belaghit, Abdelhakem, Aour, B., Larabi, M., Tadjeddine, A. A., Mebarki, S.

    “…The descending aortic aneurysm is one of the most catastrophic cardiovascular emergencies resulting in high mortality worldwide. Clinical observations have…”
    Get full text
    Journal Article
  3. 3

    Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin by Lavergne, E, Hendaoui, I, Coulouarn, C, Ribault, C, Leseur, J, Eliat, P-A, Mebarki, S, Corlu, A, Clément, B, Musso, O

    Published in Oncogene (27-01-2011)
    “…Constitutive activation of Wnt/β-catenin signaling in cancer results from mutations in pathway components, which frequently coexist with autocrine Wnt…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Temperature dependent magnetic behaviour of thin Fe(0 0 1) films with 1.5, 2, 2.5 and 3 monolayers by Hadjri-Mebarki, S., Bekhti-Siad, A., Mokrani, A., Vega, A., Khelil, A.

    Published in Surface science (10-05-2005)
    “…The magnetic properties at finite temperature of thin Fe(0 0 1) films of 1.5, 2, 2.5 and 3 monolayers (ML) are theoretically studied. The spin-polarized…”
    Get full text
    Journal Article
  7. 7

    1289PEfficacy and safety of immune checkpoint inhibitors (ICIs) for treatment of advanced solid tumours in octogenarian patients by Mebarki, S, Gisselbrecht, M, Fabre, E, Mercadier, E, Oudard, S, Paillaud, E

    Published in Annals of oncology (01-10-2019)
    “…Abstract Background The emergence of ICIs has modified the treatment of many types of cancers. However, efficacy and safety data of such agents (anti PD-1/anti…”
    Get full text
    Journal Article
  8. 8

    1289P - Efficacy and safety of immune checkpoint inhibitors (ICIs) for treatment of advanced solid tumours in octogenarian patients by Mebarki, S., Gisselbrecht, M., Fabre, E., Mercadier, E., Oudard, S., Paillaud, E.

    Published in Annals of oncology (01-10-2019)
    “…The emergence of ICIs has modified the treatment of many types of cancers. However, efficacy and safety data of such agents (anti PD-1/anti PD-L1) are cruelly…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active [beta]-catenin by Lavergne, E, Hendaoui, I, Coulouarn, C, Ribault, C, Leseur, J, Eliat, P-a, Mebarki, S, Corlu, A, Clément, B, Musso, O

    Published in Oncogene (27-01-2011)
    “…Constitutive activation of Wnt/[beta]-catenin signaling in cancer results from mutations in pathway components, which frequently coexist with autocrine Wnt…”
    Get full text
    Journal Article
  20. 20

    Influence of different dietary fats on the incorporation of exogenous fatty acids into rat adipose glycerides by Lhuillery, C, Mebarki, S, Lecourtier, M J, Demarne, Y

    Published in The Journal of nutrition (01-12-1988)
    “…Male Wistar rats were fed for 6 wk either a control low fat diet (1.5% sunflower seed oil) or a diet containing 10% fat: either saturated (coconut oil, cocoa…”
    Get more information
    Journal Article